21st Century Cures Act

Some false or misleading guidances on FDA's website.
By Bradley Merrill Thompson 11:07 am March 8, 2019
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues. The opinions in this piece are Thompson's and don't necessarily reflect the opinions of MobiHealthNews or HIMSS. As a pro bono project, together...
By Heather Mack 04:08 pm March 20, 2017
New York-based healthcare technology company, Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $11.2 million in Series A funding. Flare Capital Partners, a VC firm focused on early stage health technology and services, led the round, and Lakestar also contributed. Aetion’s Evidence Platform, which the company launched in 2015, allows...
By Heather Mack 04:44 pm December 7, 2016
The 21st Century Cures Act has passed the Senate by a 94 to 5 vote, marking the last stop before President Obama’s desk to become a law. As we reported before, The Cures Act took three years to pass and was one of the most hotly-lobbied healthcare bills in the current Congress. It passed in the House last week. The bill allocates $4.8 billion to the National Institutes of Health over the next 10...
By Heather Mack 04:29 pm November 29, 2016
The 21st Century Cures Act – a long-debated bill that would allocate extra funding to the National Institutes of Health as well as effectively speed up the FDA approval process for drugs and devices – is headed for a House vote this week. The latest version of the bill, which was released over the holiday weekend, allocates $4.8 billion to the NIH over the next 10 years. The funding would go...